Paper Details 
Original Abstract of the Article :
A systematic study in vitro and in vivo of the antispasmodic agent 2-(diethylamino)-1-methylethyl cis-1-hydroxy (bicyclohexyl)-2-carboxylate (rociverine) showed that its activity is both antimuscarinic and directly muscle-relaxant. The antimuscarinic activity is weaker than that of atropine, N-butyl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/582702

データ提供:米国国立医学図書館(NLM)

Rociverine: A Balanced Antispasmodic Agent

The search for effective antispasmodic agents is like searching for a cool breeze in a scorching desert. This research investigates the properties of [rociverine], a new antispasmodic drug that promises to provide relief from muscle spasms. The authors sought to understand the mechanism of action of this novel agent and its potential therapeutic benefits.

Rociverine: A Multifaceted Oasis

The study revealed that [rociverine] exhibits both [antimuscarinic] and [direct muscle-relaxant] activity. This unique combination makes it a powerful tool in the fight against muscle spasms. Think of it like a desert oasis that offers both shade and a cool, refreshing spring. This balanced approach allows [rociverine] to target spasms in various parts of the body, potentially providing a broader range of applications.

A Promise for Improved Spasm Management

This research suggests that [rociverine] could offer a new and effective approach to managing muscle spasms. Its unique dual mechanism of action and lack of significant side effects could make it a valuable addition to the arsenal of antispasmodic treatments. This research paves the way for more effective and targeted therapies for individuals suffering from spasms.

Dr.Camel's Conclusion

This research explores the multifaceted nature of [rociverine], revealing its potential as a balanced antispasmodic agent. This drug's unique combination of [antimuscarinic] and [direct muscle-relaxant] activity makes it a promising tool for relieving muscle spasms. Like a desert oasis offering both shade and water, [rociverine] could provide a more effective and well-rounded approach to managing muscle spasms.

Date :
  1. Date Completed 1979-11-29
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

582702

DOI: Digital Object Identifier

582702

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.